ARCHIVES

Economic Analyses Of New Therapies Useful In Phase III Studies, Trialists Say

This article is from The Cancer Letter archive.

Vol. 35 No. 29 | July 24, 2009

Download PDF Visit The Full Archive

Related Articles

ACS Journal Cancer Refers I-ELCAP Studies to Office of Human Research Protections

January 6, 2012

Commercial Labs Open Drive To Get More NIH Business, Including Grants

April 26, 1974

Vaccine and LDCT Pretreatment Can Help PDACs Become Vulnerable to Immunotherapy

June 27, 2014

USC Study Finds Increased Colon Cancer Risk For Sedentary Workers

April 13, 1984

The Varmus Era: Controversy Continues

January 6, 1995

IOM, NCI Clash Over Proposed Change in Tabulating Minority Research

January 22, 1999